Novel combination therapies targeting the ribosome to treat prostate cancer (PC)
Researchers
- Professor Ross Hannan (Primary Investigator)
- Luc Furic (Secondary Investigator)
- Rick Pearson (Secondary Investigator)
- Gail Risbridger (Secondary Investigator)
Grant status
Completed-Pending ReportsGrant start date
01/05/2015Grant funding
- 2015: $599,492 from Commonwealth Cancer Australia Agency